1308849-91-3 Usage
Description
(S)-tert-butyl 2-((1,3-dioxoisoindolin-2-yl)methyl)morpholine-4-carboxylate is a chemical compound characterized by its molecular formula C18H25NO5. It is a morpholine derivative featuring a tert-butyl group and a carboxylate functional group. (S)-tert-butyl 2-((1,3-dioxoisoindolin-2-yl)methyl)morpholine-4-carboxylate is distinguished by its unique structure and diverse properties, which may contribute to its potential applications in various fields.
Uses
Used in Pharmaceutical Industry:
(S)-tert-butyl 2-((1,3-dioxoisoindolin-2-yl)methyl)morpholine-4-carboxylate is used as a building block for the synthesis of other organic compounds due to its unique structure and properties. Its potential biological activity makes it a promising candidate for the development of new pharmaceuticals.
Used in Agrochemical Industry:
In the agrochemical industry, (S)-tert-butyl 2-((1,3-dioxoisoindolin-2-yl)methyl)morpholine-4-carboxylate is used as a starting material for the creation of novel compounds with potential applications in pest control, crop protection, and other related areas. Its unique chemical structure allows for the development of innovative products that can address various challenges in agriculture.
Further research and exploration of (S)-tert-butyl 2-((1,3-dioxoisoindolin-2-yl)methyl)morpholine-4-carboxylate's potential uses and properties are necessary to fully understand its significance and maximize its utility in different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1308849-91-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,0,8,8,4 and 9 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1308849-91:
(9*1)+(8*3)+(7*0)+(6*8)+(5*8)+(4*4)+(3*9)+(2*9)+(1*1)=183
183 % 10 = 3
So 1308849-91-3 is a valid CAS Registry Number.
1308849-91-3Relevant articles and documents
BENZIMIDAZOLE DERIVATIVES, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF
-
Page/Page column 27-28, (2022/02/24)
The present disclosure relates to benzimidazole derivatives, a preparation method therefor and a medical use thereof. Specifically, the present disclosure relates to a benzimidazole derivative represented by the general formula (I), a preparation method therefor, a pharmaceutical composition containing the derivative, and its use as a therapeutic agent, in particular its use for the treatment of diseases related to P2X3 activity.
BENZOIMIDAZOLE COMPOUNDS AND USES THEREOF
-
, (2011/06/19)
This invention generally relates to substituted benzoimidazole compounds, particularly methyl 2-((2-(2,6-difluoro-4-(methylcarbamoyl)phenyl)-5-methyl-1H- benzo[d]imidazol-1-yl)methyl)morpholine-4-carboxylate and salts thereof. This invention also relates
